Skip to main content
. 2020 Oct 19;15(10):e0240418. doi: 10.1371/journal.pone.0240418

Table 2. Normalized protein expression (NPX) values.

Benign tumors vs. cancer, p < 0.05.

Benign Cancer
Protein Mean (sd) Mean (sd) Adj. p-vala Rank
WFDC2 7.37 (0.72) 8.33 (0.64) <0.001 1
MUC-16 4.73 (1.93) 6.55 (1.40) <0.001 2
MK 7.15 (0.86) 8.04 (0.84) <0.001 3
FR-alpha 7.00 (0.75) 8.31 (1.36) <0.001 4
ITGAV 3.38 (0.27) 3.05 (0.34) <0.001 5
DNER 8.03 (0.37) 7.57 (0.48) <0.001 6
IL6 4.07 (1.31) 5.35 (1.40) <0.001 7
CDCP1 3.55 (0.72) 4.26 (0.81) <0.001 8
VEGFR-2 7.13 (0.28) 6.82 (0.35) 0.001 9
IL10 3.02 (0.61) 3.76 (0.88) 0.001 10
CXCL13 8.38 (0.80) 9.10 (0.84) 0.001 11
WISP-1 4.48 (0.60) 5.16 (0.81) 0.001 12
TNFRSF6B 4.32 (0.71) 5.03 (0.85) 0.001 13
CTSV 3.76 (0.71) 3.14 (0.71) 0.001 14
CCL23 10.04 (0.51) 10.48 (0.52) 0.001 15
CXCL1 7.66 (1.34) 8.67 (1.22) 0.002 16
SCF 9.69 (0.52) 9.09 (0.79) 0.002 17
TNFRSF4 3.32 (0.60) 3.85 (0.69) 0.002 18
CXCL11 8.10 (1.27) 9.29 (1.58) 0.002 19
VEGFA 9.88 (0.56) 10.45 (0.79) 0.003 20
CD40 9.93 (0.68) 10.55 (0.88) 0.005 21
IL-10RB 6.74 (0.34) 7.04 (0.42) 0.005 22
CSF-1 8.17 (0.30) 8.38 (0.28) 0.005 23
TNFSF14 4.53 (0.77) 5.26 (1.08) 0.005 24
CCL3 4.91 (0.70) 5.54 (0.92) 0.005 25
SCAMP3 3.03 (1.82) 4.61 (2.33) 0.006 26
CXCL6 7.53 (1.29) 8.50 (1.42) 0.006 27
ABL1 2.79 (1.63) 4.32 (2.37) 0.008 28
TXLNA 4.01 (1.92) 5.58 (2.42) 0.008 29
IL-17C 1.48 (0.63) 2.30 (1.32) 0.008 30
PVRL4 6.10 (0.65) 6.75 (1.03) 0.008 31
IL8 6.26 (1.26) 7.04 (1.13) 0.008 32
IL-18R1 7.05 (0.47) 7.41 (0.55) 0.008 33
RSPO3 3.81 (0.61) 4.37 (0.89) 0.008 34
TFPI-2 7.78 (0.63) 8.31 (0.82) 0.008 35
MCP-1 10.14 (0.55) 10.58 (0.69) 0.008 36
CXCL9 7.70 (1.24) 8.46 (1.13) 0.008 37
ICOSLG 3.90 (0.29) 3.65 (0.39) 0.008 38
PD-L1 3.79 (0.45) 4.18 (0.61) 0.008 39
TNFRSF9 6.20 (0.63) 6.66 (0.73) 0.008 40
IL-15RA 0.35 (0.18) 0.50 (0.24) 0.008 41
DKN1A 2.36 (2.33) 4.19 (2.95) 0.009 42
LYN 1.17 (1.11) 1.94 (1.27) 0.011 43
LYPD3 4.07 (0.48) 3.70 (0.61) 0.011 44
FASLG 8.90 (0.57) 8.54 (0.57) 0.012 45
ADAM-TS 15 4.33 (0.58) 4.76 (0.71) 0.012 46
OPG 10.66 (0.30) 10.94 (0.48) 0.012 47
ESM-1 8.92 (0.48) 9.25 (0.56) 0.014 48
MMP-1 12.32 (1.37) 13.36 (1.84) 0.018 49
EGF 6.25 (2.23) 7.74 (2.62) 0.018 50
SYND1 6.46 (0.67) 6.94 (0.85) 0.018 51
MSLN 2.18 (0.88) 2.89 (1.33) 0.021 52
IL7 3.59 (1.21) 4.35 (1.39) 0.023 53
LAP TGF-beta-1 7.53 (0.67) 8.00 (0.88) 0.023 54
TNFSF13 8.39 (0.39) 8.65 (0.47) 0.025 55
VIM 3.47 (1.32) 4.07 (1.01) 0.025 56
IL-12B 4.38 (0.70) 4.80 (0.77) 0.027 57
SEZ6L 5.33 (0.40) 5.06 (0.51) 0.027 58
hK11 5.79 (0.77) 6.35 (1.07) 0.027 59
SIRT2 3.38 (1.99) 4.66 (2.46) 0.028 60
EPHA2 1.46 (0.46) 1.79 (0.64) 0.028 61
4E-BP1 8.82 (1.31) 9.52 (1.29) 0.028 62
TNFRSF19 4.06 (0.49) 4.46 (0.77) 0.028 63
FURIN 4.02 (0.46) 4.29 (0.50) 0.029 64
CCL4 6.44 (0.60) 6.91 (0.93) 0.029 65
FADD 0.75 (1.22) 1.52 (1.51) 0.029 66
AXIN1 3.55 (2.20) 5.03 (2.93) 0.029 67
MCP-4 3.74 (1.10) 4.31 (1.08) 0.029 68
CEACAM1 7.56 (0.17) 7.43 (0.23) 0.029 69
CD27 7.85 (0.43) 8.14 (0.58) 0.029 70
HGF 8.39 (0.54) 8.78 (0.79) 0.031 71
FGF-21 5.82 (1.52) 6.69 (1.72) 0.034 72
STAMPB 4.90 (1.67) 5.96 (2.15) 0.034 73
MetAP 2 4.18 (1.06) 4.79 (1.25) 0.035 74
CASP-8 1.19 (0.76) 1.69 (1.04) 0.038 75
TNFB 3.92 (0.39) 3.60 (0.72) 0.043 76
CCL20 5.59 (1.22) 6.19 (1.28) 0.049 77
ST1A1 1.16 (1.29) 1.94 (1.69) 0.049 78

a p-values adjusted with FDR.